KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Financing Activities (2016 - 2025)

Thermo Fisher Scientific's Cash from Financing Activities history spans 17 years, with the latest figure at $3.5 billion for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 196.18% year-over-year to $3.5 billion, compared with a TTM value of $1.8 billion through Dec 2025, up 126.52%, and an annual FY2025 reading of $1.8 billion, up 126.52% over the prior year.
  • Cash from Financing Activities for Q4 2025 was $3.5 billion at Thermo Fisher Scientific, up from -$632.0 million in the prior quarter.
  • The five-year high for Cash from Financing Activities was $8.5 billion in Q4 2021, with the low at -$4.9 billion in Q2 2021.
  • Average Cash from Financing Activities over 5 years is -$242.1 million, with a median of -$811.5 million recorded in 2025.
  • Year-over-year, Cash from Financing Activities soared 17379.59% in 2021 and then tumbled 2406.58% in 2022.
  • Tracing TMO's Cash from Financing Activities over 5 years: stood at $8.5 billion in 2021, then tumbled by 71.76% to $2.4 billion in 2022, then tumbled by 159.72% to -$1.4 billion in 2023, then plummeted by 156.72% to -$3.7 billion in 2024, then surged by 196.18% to $3.5 billion in 2025.
  • Per Business Quant, the three most recent readings for TMO's Cash from Financing Activities are $3.5 billion (Q4 2025), -$632.0 million (Q3 2025), and -$991.0 million (Q2 2025).